Plcoskin Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$9.9M
- Investors
-
16
Plcoskin General Information
Description
Developer of reconstructive medical devices designed to offer a two-track strategy encompassing breast reconstruction and fillers. The company's devices offer skin regenerating sheets mainly for patients who have breast tissue from breast cancer, which reduces reconstruction surgery costs, enabling patients to have a safer surgery.
Contact Information
Website
www.plcoskin.comCorporate Office
- Daishin Building
- 519 Seongsan-ro, Seodaemun-gu
- Seoul, 03721
- South Korea
Corporate Office
- Daishin Building
- 519 Seongsan-ro, Seodaemun-gu
- Seoul, 03721
- South Korea
Plcoskin Timeline
Plcoskin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series C) | 15-Dec-2025 | $9.9M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series B) | 31-Aug-2023 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 11-Jul-2022 | Completed | Generating Revenue | |||
| 4. Grant | 29-Jul-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Jan-2020 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Sep-2019 | $413K | $413K | Completed | Startup | |
| 1. Seed Round | 31-Jul-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Plcoskin Patents
Plcoskin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026216872-A1 | Biocompatible polymer having improved tissue restoration efficiency and use thereof | Pending | 11-Apr-2025 | ||
| WO-2026095683-A1 | Tissue-restoring biodegradable composite structure having uniform porosity | Pending | 31-Oct-2024 | ||
| WO-2025155144-A1 | Human body-implantable device for treating urinary incontinence comprising composite material | Pending | 18-Jan-2024 | ||
| WO-2025100945-A1 | Novel implantable device for treating urinary incontinence in human body | Inactive | 07-Nov-2023 | ||
| WO-2025041060-A1 | Patient-derived xenograft model of cancer, preparation method thereof and an apparatus and a method for analyzing drug responsiveness using the same | Inactive | 21-Aug-2023 | G01N33/5011 |
Plcoskin Signals
Plcoskin Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BNH Investment | Venture Capital | Minority | ||
| Daebong Life Science | Corporation | Minority | ||
| Highlight Capital | Venture Capital | Minority | ||
| SBI Investment | Venture Capital | Minority | ||
| Helios Investment Partners | PE/Buyout | Minority |
Plcoskin FAQs
-
When was Plcoskin founded?
Plcoskin was founded in 2017.
-
Where is Plcoskin headquartered?
Plcoskin is headquartered in Seoul, South Korea.
-
What is the size of Plcoskin?
Plcoskin has 24 total employees.
-
What industry is Plcoskin in?
Plcoskin’s primary industry is Surgical Devices.
-
Is Plcoskin a private or public company?
Plcoskin is a Private company.
-
What is Plcoskin’s current revenue?
The current revenue for Plcoskin is .
-
How much funding has Plcoskin raised over time?
Plcoskin has raised $16.1M.
-
Who are Plcoskin’s investors?
BNH Investment, Daebong Life Science, Highlight Capital, SBI Investment, and Helios Investment Partners are 5 of 16 investors who have invested in Plcoskin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process